pyrimidine has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbachyn, MR; Cai, H; Chen, H; Gage, JW; Hanna, DL; Huband, MD; Lall, MS; Lockard, M; McCurdy, SP; Mullins, LM; Owen, RM; Rauckhorst, MR; Sciotti, RJ; Starr, JT; Tomilo, M | 1 |
| AMIEL, JL; CATTAN, A; MATHE, G; SCHLUMBERGER, JR; SCHNEIDER, M; SCHWARZENBERG, L | 1 |
2 other study(ies) available for pyrimidine and Sepsis
| Article | Year |
|---|---|
5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV.
Topics: Animals; Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Gram-Positive Bacteria; Imidazoles; Lung; Mice; Microbial Sensitivity Tests; Pyridines; Pyrimidines; Rats; Sepsis; Structure-Activity Relationship | 2009 |
[TRIAL TREATMENT OF VARIOUS "PROTEUS" INFECTIONS WITH 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL) PYRIMIDINE, OR (TRIM'ETHOPRIME)].
Topics: Drug Synergism; Drug Therapy; Folic Acid; Hematologic Diseases; Humans; Metabolism; Neoplasms; Polymethacrylic Acids; Proteus; Proteus Infections; Pyrimidines; Respiratory Tract Infections; Sepsis; Skin Diseases; Sulfonamides; Urinary Tract Infections | 1965 |